Sinopharm Group Co. Ltd. (HKG:1099)

Sinopharm Group Revenue

Sinopharm Group had revenue of 142.03B CNY in the quarter ending June 30, 2026, a decrease of -1.63%. This brings the company's total for the last twelve months to 571.92B, down -0.68% year-over-year. In the year 2025, Sinopharm Group had annual revenue of 575.17B, down -1.60%. That makes Sinopharm Group the 130th largest company in the world by revenue and 18th in Hong Kong.

• Revenue (ttm): 571.92B CNY
• Revenue Growth: -0.68%
• P/S Ratio: 0.07
• Revenue / Employee: 6.32M CNY
• Employees: 90,447
• Market Cap: 48.21B HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue by Segment

Chart

• Pharmaceutical Distribution 435.39B 72.8%
• Medical Device Distribution 115.54B 19.3%
• Retail Pharmacy 38.38B 6.4%
• Other Business 8.85B 1.5%

Fiscal year ended Dec 31, 2025 See the full Sinopharm Group breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	575.17B	-9.34B	-1.60%
Dec 31, 2024	584.51B	-12.06B	-2.02%
Dec 31, 2023	596.57B	44.42B	8.05%
Dec 31, 2022	552.15B	31.10B	5.97%
Dec 31, 2021	521.05B	64.64B	14.16%

Data Source: S&P Global Market Intelligence Last updated: Sep 22, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 20, 2026

Data Sources Report a data error